{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T22:25:06Z","timestamp":1791498306606,"version":"4.3.4"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,30]],"date-time":"2021-10-30T00:00:00Z","timestamp":1635552000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,10,30]],"date-time":"2021-10-30T00:00:00Z","timestamp":1635552000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001659","name":"deutsche forschungsgemeinschaft","doi-asserted-by":"crossref","award":["DA 1657\/2-1"],"award-info":[{"award-number":["DA 1657\/2-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001659","name":"deutsche forschungsgemeinschaft","doi-asserted-by":"crossref","award":["GRK 1789"],"award-info":[{"award-number":["GRK 1789"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Deutsches Zentrum f\u00fcr Neurodegenerative Erkrankungen e.V. (DZNE) in der Helmholtz-Gemeinschaft"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The dysregulation of peripheral immunity in Parkinson\u2019s Disease (PD) includes changes in both the relative numbers and gene expression of T cells. The presence of peripheral T-cell abnormalities in PD is well-documented, but less is known about their association to clinical parameters, such as age, age of onset, progression rate or severity of the disease. We took a detailed look at T-cell numbers, gene expression and activation in cross-sectional cohorts of PD patients and age-matched healthy controls by means of flow cytometry and NanoString gene expression assay. We show that the well-pronounced decrease in relative T-cell numbers in PD blood is mostly driven by a decrease of CD8\n                    <jats:sup>+<\/jats:sup>\n                    cytotoxic T cells and is primarily associated with the severity of the disease. In addition, we demonstrate that the expression of inflammatory genes in T cells from PD patients is also associated with disease severity. PD T cells presented with increased activation upon stimulation with phytohemagglutinin that also correlated with disease severity. In summary, our data suggest that the consequences of disease severity account for the changes in PD T cells, rather than age, age of onset, duration or the disease progression rate.\n                  <\/jats:p>","DOI":"10.1186\/s12974-021-02296-8","type":"journal-article","created":{"date-parts":[[2021,10,30]],"date-time":"2021-10-30T07:02:43Z","timestamp":1635577363000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":65,"title":["T-cell dysregulation is associated with disease severity in Parkinson\u2019s Disease"],"prefix":"10.1186","volume":"18","author":[{"given":"Divisha","family":"Bhatia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veselin","family":"Grozdanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang P.","family":"Ruf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Kassubek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert C.","family":"Ludolph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochen H.","family":"Weishaupt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin M.","family":"Danzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,30]]},"reference":[{"key":"2296_CR1","first-page":"182","volume":"119","author":"V Brochard","year":"2009","unstructured":"Brochard V, Combadiere B, Prigent A, Laouar Y, Perrin A, Beray-Berthat V, Bonduelle O, Alvarez-Fischer D, Callebert J, Launay JM, et al. Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease. J Clin Invest. 2009;119:182\u201392.","journal-title":"J Clin Invest"},{"key":"2296_CR2","doi-asserted-by":"crossref","unstructured":"Grozdanov V, Bliederhaeuser C, Ruf WP, Roth V, Fundel-Clemens K, Zondler L, Brenner D, Martin-Villalba A, Hengerer B, Kassubek J, et al. Inflammatory dysregulation of blood monocytes in Parkinson\u2019s disease patients. Acta Neuropathol 2014; 128:651\u2013663.","DOI":"10.1007\/s00401-014-1345-4"},{"key":"2296_CR3","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s00401-021-02268-5","volume":"141","author":"AS Harms","year":"2021","unstructured":"Harms AS, Ferreira SA, Romero-Ramos M. Periphery and brain, innate and adaptive immunity in Parkinson\u2019s disease. Acta Neuropathol. 2021;141:527\u201345.","journal-title":"Acta Neuropathol"},{"key":"2296_CR4","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/bs.pbr.2019.10.006","volume":"252","author":"AM Schonhoff","year":"2020","unstructured":"Schonhoff AM, Williams GP, Wallen ZD, Standaert DG, Harms AS. Innate and adaptive immune responses in Parkinson\u2019s disease. Prog Brain Res. 2020;252:169\u2013216.","journal-title":"Prog Brain Res"},{"key":"2296_CR5","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1186\/s12974-018-1206-5","volume":"15","author":"CH Williams-Gray","year":"2018","unstructured":"Williams-Gray CH, Wijeyekoon RS, Scott KM, Hayat S, Barker RA, Jones JL. Abnormalities of age-related T cell senescence in Parkinson\u2019s disease. J Neuroinflammation. 2018;15:166.","journal-title":"J Neuroinflammation"},{"key":"2296_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nbd.2009.12.017","volume":"38","author":"M Calopa","year":"2010","unstructured":"Calopa M, Bas J, Callen A, Mestre M. Apoptosis of peripheral blood lymphocytes in Parkinson patients. Neurobiol Dis. 2010;38:1\u20137.","journal-title":"Neurobiol Dis"},{"key":"2296_CR7","doi-asserted-by":"publisher","first-page":"815","DOI":"10.3389\/fneur.2018.00815","volume":"9","author":"KM Scott","year":"2018","unstructured":"Scott KM, Kouli A, Yeoh SL, Clatworthy MR, Williams-Gray CH. A systematic review and meta-analysis of alpha synuclein auto-antibodies in Parkinson\u2019s Disease. Front Neurol. 2018;9:815.","journal-title":"Front Neurol"},{"key":"2296_CR8","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/nature22815","volume":"546","author":"D Sulzer","year":"2017","unstructured":"Sulzer D, Alcalay RN, Garretti F, Cote L, Kanter E, Agin-Liebes J, Liong C, McMurtrey C, Hildebrand WH, Mao X, et al. T cells from patients with Parkinson\u2019s disease recognize alpha-synuclein peptides. Nature. 2017;546:656\u201361.","journal-title":"Nature"},{"key":"2296_CR9","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1136\/jnnp.2008.162883","volume":"81","author":"M Saiki","year":"2010","unstructured":"Saiki M, Baker A, Williams-Gray CH, Foltynie T, Goodman RS, Taylor CJ, Compston DA, Barker RA, Sawcer SJ, Goris A. Association of the human leucocyte antigen region with susceptibility to Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry. 2010;81:890\u20131.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2296_CR10","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1038\/ng.3043","volume":"46","author":"MA Nalls","year":"2014","unstructured":"Nalls MA, Pankratz N, Lill CM, Do CB, Hernandez DG, Saad M, DeStefano AL, Kara E, Bras J, Sharma M, et al. Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson\u2019s disease. Nat Genet. 2014;46:989\u201393.","journal-title":"Nat Genet"},{"key":"2296_CR11","first-page":"11","volume":"2020","author":"CS Lindestam Arlehamn","year":"1875","unstructured":"Lindestam Arlehamn CS, Dhanwani R, Pham J, Kuan R, Frazier A, Rezende Dutra J, Phillips E, Mallal S, Roederer M, Marder KS, et al. alpha-Synuclein-specific T cell reactivity is associated with preclinical and early Parkinson\u2019s disease. Nat Commun. 1875;2020:11.","journal-title":"Nat Commun"},{"key":"2296_CR12","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1111\/j.1600-0404.1994.tb02699.x","volume":"90","author":"U Fiszer","year":"1994","unstructured":"Fiszer U, Mix E, Fredrikson S, Kostulas V, Link H. Parkinson\u2019s disease and immunological abnormalities: increase of HLA-DR expression on monocytes in cerebrospinal fluid and of CD45RO+ T cells in peripheral blood. Acta Neurol Scand. 1994;90:160\u20136.","journal-title":"Acta Neurol Scand"},{"key":"2296_CR13","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/0022-510X(94)90154-6","volume":"121","author":"U Fiszer","year":"1994","unstructured":"Fiszer U, Mix E, Fredrikson S, Kostulas V, Olsson T, Link H. gamma delta+ T cells are increased in patients with Parkinson\u2019s disease. J Neurol Sci. 1994;121:39\u201345.","journal-title":"J Neurol Sci"},{"key":"2296_CR14","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/S0165-5728(00)00422-7","volume":"113","author":"J Bas","year":"2001","unstructured":"Bas J, Calopa M, Mestre M, Mollevi DG, Cutillas B, Ambrosio S, Buendia E. Lymphocyte populations in Parkinson\u2019s disease and in rat models of parkinsonism. J Neuroimmunol. 2001;113:146\u201352.","journal-title":"J Neuroimmunol"},{"key":"2296_CR15","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1001\/archneur.58.10.1580","volume":"58","author":"K Hisanaga","year":"2001","unstructured":"Hisanaga K, Asagi M, Itoyama Y, Iwasaki Y. Increase in peripheral CD4 bright+ CD8 dull+ T cells in Parkinson disease. Arch Neurol. 2001;58:1580\u20133.","journal-title":"Arch Neurol"},{"key":"2296_CR16","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.parkreldis.2005.07.005","volume":"11","author":"Y Baba","year":"2005","unstructured":"Baba Y, Kuroiwa A, Uitti RJ, Wszolek ZK, Yamada T. Alterations of T-lymphocyte populations in Parkinson disease. Parkinsonism Relat Disord. 2005;11:493\u20138.","journal-title":"Parkinsonism Relat Disord"},{"key":"2296_CR17","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.jneuroim.2010.12.001","volume":"233","author":"MA Gruden","year":"2011","unstructured":"Gruden MA, Sewell RD, Yanamandra K, Davidova TV, Kucheryanu VG, Bocharov EV, Bocharova OA, Polyschuk VV, Sherstnev VV, Morozova-Roche LA. Immunoprotection against toxic biomarkers is retained during Parkinson\u2019s disease progression. J Neuroimmunol. 2011;233:221\u20137.","journal-title":"J Neuroimmunol"},{"key":"2296_CR18","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1007\/s11481-012-9402-z","volume":"7","author":"JA Saunders","year":"2012","unstructured":"Saunders JA, Estes KA, Kosloski LM, Allen HE, Dempsey KM, Torres-Russotto DR, Meza JL, Santamaria PM, Bertoni JM, Murman DL, et al. CD4+ regulatory and effector\/memory T cell subsets profile motor dysfunction in Parkinson\u2019s disease. J Neuroimmune Pharmacol. 2012;7:927\u201338.","journal-title":"J Neuroimmune Pharmacol"},{"key":"2296_CR19","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jneuroim.2012.07.015","volume":"252","author":"CH Stevens","year":"2012","unstructured":"Stevens CH, Rowe D, Morel-Kopp MC, Orr C, Russell T, Ranola M, Ward C, Halliday GM. Reduced T helper and B lymphocytes in Parkinson\u2019s disease. J Neuroimmunol. 2012;252:95\u20139.","journal-title":"J Neuroimmunol"},{"key":"2296_CR20","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.neulet.2017.03.045","volume":"648","author":"S Chen","year":"2017","unstructured":"Chen S, Liu Y, Niu Y, Xu Y, Zhou Q, Xu X, Wang J, Yu M. Increased abundance of myeloid-derived suppressor cells and Th17 cells in peripheral blood of newly-diagnosed Parkinson\u2019s disease patients. Neurosci Lett. 2017;648:21\u20135.","journal-title":"Neurosci Lett"},{"key":"2296_CR21","doi-asserted-by":"publisher","first-page":"6105","DOI":"10.3892\/mmr.2015.4136","volume":"12","author":"Y Chen","year":"2015","unstructured":"Chen Y, Qi B, Xu W, Ma B, Li L, Chen Q, Qian W, Liu X, Qu H. Clinical correlation of peripheral CD4+cell subsets, their imbalance and Parkinson\u2019s disease. Mol Med Rep. 2015;12:6105\u201311.","journal-title":"Mol Med Rep"},{"key":"2296_CR22","first-page":"2495","volume":"8","author":"Y Chen","year":"2015","unstructured":"Chen Y, Yu M, Liu X, Qu H, Chen Q, Qian W, Wei D, Xu W, Ma B, Wu W. Clinical characteristics and peripheral T cell subsets in Parkinson\u2019s disease patients with constipation. Int J Clin Exp Pathol. 2015;8:2495\u2013504.","journal-title":"Int J Clin Exp Pathol"},{"key":"2296_CR23","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.stem.2018.06.015","volume":"23","author":"A Sommer","year":"2018","unstructured":"Sommer A, Marxreiter F, Krach F, Fadler T, Grosch J, Maroni M, Graef D, Eberhardt E, Riemenschneider MJ, Yeo GW, et al. Th17 lymphocytes induce neuronal cell death in a human iPSC-based model of Parkinson\u2019s Disease. Cell Stem Cell. 2018;23:123\u201331.","journal-title":"Cell Stem Cell"},{"key":"2296_CR24","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1186\/s12974-018-1248-8","volume":"15","author":"N Kustrimovic","year":"2018","unstructured":"Kustrimovic N, Comi C, Magistrelli L, Rasini E, Legnaro M, Bombelli R, Aleksic I, Blandini F, Minafra B, Riboldazzi G, et al. Parkinson\u2019s disease patients have a complex phenotypic and functional Th1 bias: cross-sectional studies of CD4+ Th1\/Th2\/T17 and Treg in drug-naive and drug-treated patients. J Neuroinflammation. 2018;15:205.","journal-title":"J Neuroinflammation"},{"key":"2296_CR25","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/s12974-019-1606-1","volume":"16","author":"DD Alvarez-Luquin","year":"2019","unstructured":"Alvarez-Luquin DD, Arce-Sillas A, Leyva-Hernandez J, Sevilla-Reyes E, Boll MC, Montes-Moratilla E, Vivas-Almazan V, Perez-Correa C, Rodriguez-Ortiz U, Espinoza-Cardenas R, et al. Regulatory impairment in untreated Parkinson\u2019s disease is not restricted to Tregs: other regulatory populations are also involved. J Neuroinflammation. 2019;16:212.","journal-title":"J Neuroinflammation"},{"key":"2296_CR26","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41531-021-00188-5","volume":"7","author":"AD Thome","year":"2021","unstructured":"Thome AD, Atassi F, Wang J, Faridar A, Zhao W, Thonhoff JR, Beers DR, Lai EC, Appel SH. Ex vivo expansion of dysfunctional regulatory T lymphocytes restores suppressive function in Parkinson\u2019s disease. NPJ Parkinsons Dis. 2021;7:41.","journal-title":"NPJ Parkinsons Dis"},{"key":"2296_CR27","first-page":"687","volume":"32","author":"ZX Hu","year":"2018","unstructured":"Hu ZX, Song WN, Lu XD, Zhou ML, Shao JH. Peripheral T lymphocyte immunity and l-dopamine in patients with Parkinson\u2019s disease. J Biol Regul Homeost Agents. 2018;32:687\u201391.","journal-title":"J Biol Regul Homeost Agents"},{"key":"2296_CR28","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1212\/WNL.17.5.427","volume":"17","author":"MM Hoehn","year":"1967","unstructured":"Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology. 1967;17:427\u201342.","journal-title":"Neurology"},{"key":"2296_CR29","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1002\/ana.25557","volume":"86","author":"V Grozdanov","year":"2019","unstructured":"Grozdanov V, Bousset L, Hoffmeister M, Bliederhaeuser C, Meier C, Madiona K, Pieri L, Kiechle M, McLean PJ, Kassubek J, et al. Increased immune activation by pathologic alpha-synuclein in Parkinson\u2019s Disease. Ann Neurol. 2019;86:593\u2013606.","journal-title":"Ann Neurol"},{"key":"2296_CR30","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550.","journal-title":"Genome Biol"},{"key":"2296_CR31","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25:402\u20138.","journal-title":"Methods"},{"key":"2296_CR32","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/j.2517-6161.1991.tb01857.x","volume":"53","author":"SJ Sheather","year":"1991","unstructured":"Sheather SJ, Jones MC. A reliable data-based bandwidth selection method for kernel density estimation. J Roy Stat Soc: Ser B (Methodol). 1991;53:683\u201390.","journal-title":"J Roy Stat Soc: Ser B (Methodol)"},{"key":"2296_CR33","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y. Controlling the false discovery rate\u2014a practical and powerful approach to multiple testing. J Roy Stat Soc Ser B-Methodol. 1995;57:289\u2013300.","journal-title":"J Roy Stat Soc Ser B-Methodol"},{"key":"2296_CR34","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1186\/1471-2105-9-559","volume":"9","author":"P Langfelder","year":"2008","unstructured":"Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics. 2008;9:559.","journal-title":"BMC Bioinformatics"},{"key":"2296_CR35","doi-asserted-by":"crossref","unstructured":"Langfelder P, Horvath S. Fast R functions for robust correlations and hierarchical clustering. J Stat Softw 2012; 46.","DOI":"10.18637\/jss.v046.i11"},{"key":"2296_CR36","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1093\/brain\/awab103","volume":"144","author":"GP Williams","year":"2021","unstructured":"Williams GP, Schonhoff AM, Jurkuvenaite A, Gallups NJ, Standaert DG, Harms AS. CD4 T cells mediate brain inflammation and neurodegeneration in a mouse model of Parkinson\u2019s disease. Brain. 2021;144:2047\u201359.","journal-title":"Brain"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-021-02296-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12974-021-02296-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-021-02296-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T23:37:54Z","timestamp":1726011474000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/s12974-021-02296-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,30]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2296"],"URL":"https:\/\/doi.org\/10.1186\/s12974-021-02296-8","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,30]]},"assertion":[{"value":"9 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experimental work with human samples was carried out in agreement with the Declaration of Helsinki and under the approval of the Ethics Committee of the University of Ulm, Germany. All study participants provided informed written consent to participate in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"250"}}